Search - tctmd.com

Displaying 201 - 220 of 315

Sort: Relevancy | Date

Presentation

Thrombectomy Within 8 Hours After Symptom Onset in Ischemic Stroke

Presenter: T.G. Jovin

April 28, 2015

Presentation

Long-term Effects of Ischemic Postconditioning on Clinical Outcomes

Presenter: J-Y Hahn

March 13, 2015

Presentation

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

Presenter: M. Goyal

February 10, 2015

Presentation

Endovascular Therapy for Ischemic Stroke With Perfusion-Imaging Selection

Presenter: B.C.V. Campbell

February 10, 2015

Presentation

ICSS-MRI Analysis: Ischemic Brain Lesions After CAS Increase Future Cerebrovascular Risk

Presenter: H. Gensicke

February 08, 2015

Presentation

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

Presenter: O.A. Berkhemer

December 16, 2014

Presentation ICI 2014

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Presenter: Amir Belson

December 14, 2014

Presentation ICI 2014

SPG Stimulation for Treatment of Acute Ischemic Stroke

Presenter: Yoram Solberg

December 14, 2014

Presentation

New Ischemic Stroke and Outcomes With Vorapaxar vs Placebo

Presenter: B.P. Bonaca

December 02, 2014

Presentation Cardiovascular Interventions 2014

Stem Cells for Ischemic Heart Disease

Presenter: Richard A. Shatz

October 23, 2014

Presentation TCT 2014

TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk

Presenter: John M. Lasala, Stuart J. Pocock, George Hanzel, MD

September 16, 2014

Presentation TCT 2014

TCT 482: Effect of Cangrelor on Ischemic Endpoints: Further Analyses From CHAMPION PHOENIX

Presenter: John M. Lasala, Stuart J. Pocock, Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Presenter: Alok Saurav

September 16, 2014

Presentation TCT 2014

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Presenter: Deepak Bhatt

September 16, 2014

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

Presentation TCT 2014

Complete revascularization in ischemic heart failure may improve patient survival

Presenter: Lukasz Pyka

September 16, 2014

Presentation TCT 2014

Vagal Nerve Neuromodulation for Ischemic HF Therapy

Presenter: Daniel Burkhoff, Felix Mahfoud, Jose Luis Assad-Morell, Sahil A. Parikh, Gaetano De Ferrari

September 15, 2014

Presentation TCT 2014

TCT 75: Complete Revascularization in Ischemic Heart Failure May Improve Patient Survival

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Lukasz Pyka

September 15, 2014

Presentation TCT 2014

TCT 76: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute® Device in Patients with Ischemic Dilated Heart Failure: Primary Endpoint Results of the European Postmarket Trial - PARACHUTE III

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Ulrich Schaefer, MD

September 15, 2014

Presentation TCT 2014

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Presenter: Frank Litvack, Todd J. Brinton

September 14, 2014

Advertisement

Thrombectomy Within 8 Hours After Symptom Onset in Ischemic Stroke

Long-term Effects of Ischemic Postconditioning on Clinical Outcomes

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

Endovascular Therapy for Ischemic Stroke With Perfusion-Imaging Selection

ICSS-MRI Analysis: Ischemic Brain Lesions After CAS Increase Future Cerebrovascular Risk

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

SPG Stimulation for Treatment of Acute Ischemic Stroke

New Ischemic Stroke and Outcomes With Vorapaxar vs Placebo

Stem Cells for Ischemic Heart Disease

TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk

TCT 482: Effect of Cangrelor on Ischemic Endpoints: Further Analyses From CHAMPION PHOENIX

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Complete revascularization in ischemic heart failure may improve patient survival

Vagal Nerve Neuromodulation for Ischemic HF Therapy

TCT 75: Complete Revascularization in Ischemic Heart Failure May Improve Patient Survival

TCT 76: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute® Device in Patients with Ischemic Dilated Heart Failure: Primary Endpoint Results of the European Postmarket Trial - PARACHUTE III

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content